A biopharmaceutical company developing small molecule, antiviral drug treatments for the treatment of autoimmune diseases, neuropathic pain, liver diseases and cancer
1
Funding Rounds
$10.0m
Money raised
The company Virobay has raised a total of $10m in funding over 1 rounds.